Edwards Lifesciences is recalling the Sapien 3 Ultra delivery system after receiving reports of burst balloons during implantation procedures, which have resulted in significant difficulty...
Heart Valve Technology
This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve replacement (TMVR), transcatheter and surgical valve repairs, ad surgical replacement valves.
-
-
In one coordinated move, the U.S. Food and Drug Administration (FDA) opened transcatheter aortic valve replacement (TAVR) to low-risk patients with the simultaneous approvals of Edwards...
-
As we usher in a new era for treating patients with aortic stenosis, we have been reflecting on the evolution of the technology used for transcatheter aortic valve replacement (TAVR) and the...
-
Joao Cavalcante, M.D., FSCCT, director of structural heart CT and cardiac MRI,...
News | Heart Valve Technology | August 22, 2019
August 22, 2019 — Edwards Lifesciences is recalling the Sapien 3 Ultra...
Paul Tang, M.D., Ph.D., a cardiac surgeon at Michigan Medicine’s Frankel Cardiovascular Center in the OR. Image courtesy of Michigan Medicine.
News | Ventricular Assist Devices (VAD) | August 20, 2019
August 20, 2019 — Left...
Left, an illustration of the beginning of deployment for a CoreValve Evolut self-expanding transcatheter aortic replacement (TAVR) valve. Right, an illustration of the final balloon expansion of an Edwards Lifesciences Sapien 3 TAVR valve. Both valves received simultaneous FDA clearance for use in low-risk surgical patients. Clearing this last hurdle now allows wide-spread use of minimally invasive TAVR in all patients who otherwise would need an open-heart surgical valve replacement.
Feature | Heart Valve Technology | August 16, 2019 | Jeff Zagoudis, Associate Editor, and Dave Fornell, Editor
August 16, 2019 — In one coordinated move, the U.S. Food and Drug Administration (FDA) opened use of ...
Example of an aortic valve CT imaging workup for TAVR valve sizing and assessing access routes. This patient has an aneurism in the aortic arch. Image from GE Healthcare.
Feature | Structural Heart | August 12, 2019 | Ashish Pershad, M.D., and Kenith Fang, M.D., FACS
As we usher in a new era for treating patients with aortic stenosis, we have been reflecting on the evolution of the...
News | Embolic Protection Devices | July 19, 2019
July 19, 2019 — Medical device startup company Filterlex Medical recently completed a series A financing round,...
Technology | Heart Valve Technology | July 17, 2019
July 17, 2019 — Abbott has received U.S. Food and Drug Administration (FDA) approval for the most advanced MitraClip...
News | Heart Valve Technology | July 09, 2019
July 9, 2019 — Neovasc Inc. announced that its Tiara...
News | Stethoscopes | July 08, 2019
July 8, 2019 — Berkeley, Calif.-based digital health company Eko unveiled an investigational...
News | Structural Heart | July 05, 2019
July 5, 2019 — FEops announced that FEops HEARTguide was the winning entry at CSI Frankfurt 2019 voted on by...
This image shows a left-ventricular outflow tract (LVOT) obstructed by an Edwards Sapien TAVR valve used for a valve-in-valve procedure. The arrow points to the small, crescent shaped dark area of the neo-LVOT, which did not allow enough blood to flow from the left ventricle into the aorta and the rest of the body. To prevent this issue, the procedure used by Henry Ford ablates (kills) some of the tissue in the cardiac septum to allow these valves to fit better and allow for an enlarged neo-LVOT for patients who otherwise could not receive this therapy.
News | Heart Valve Technology | July 03, 2019
July 3, 2019 — A ...
Videos | Heart Failure | June 28, 2019
Feature | Heart Valve Technology | June 24, 2019
June 24, 2019 — The Centers for Medicare and Medicaid Services (CMS) recently finalized its decision to update the...
News | Cath Lab | June 20, 2019
June 20, 2019 – VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between...
